Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.
Neophytou CM, Trougakos IP, Erin N, Papageorgis P. · 2021
Read Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. by Neophytou CM, Trougakos IP, Erin N, Papageorgis P. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8430856.txt.
Introduction
Neophytou and co-authors explain how broken cell-death control helps cancers resist many drugs at once. Multi-drug resistance means a tumor shrugs off agents that work in unlike ways. Faulty apoptosis, or programmed cell death, is a chief driver of that state.
The review maps the major apoptotic pathways first. It shows how cancer cells tune pro-death and pro-life proteins to gain an edge. Signals for survival and death cross-talk inside the cell. The tumor surroundings also help block death signals. Chemical marks on DNA form one more lever. The authors end with current and future ways to beat this resistance.
Catalog record
| CREATOR | Neophytou CM, Trougakos IP, Erin N, Papageorgis P. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |